Diseases /

Ovarian Adenocarcinoma

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: An adenocarcinoma that arises from the ovary. It is the most common type of ovarian carcinoma. It includes the serous adenocarcinoma, mucinous adenocarcinoma, clear cell adenocarcinoma, and endometrioid adenocarcinoma. [1]

Ovarian adenocarcinomas most frequently harbor alterations in TP53, KRAS, CCNE1, PIK3CA, and NF1 [2].

Most Commonly Altered Genes in Ovarian Adenocarcinoma

TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, TP53 Exon 5 Mutation, and TP53 Exon 8 Mutation are the most common alterations in ovarian adenocarcinoma [2].

Top Alterations in Ovarian Adenocarcinoma

Clinical Trials

View Clinical Trials for Ovarian Adenocarcinoma

Disease Details

Synonyms
Adenocarcinoma of the Ovary, Adenocarcinoma of Ovary
Parent(s)
Ovarian Carcinoma
Children
Ovarian Mucinous Adenocarcinoma, Ovarian Cystadenocarcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, and Ovarian Serous Adenocarcinoma

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.